Dr. Paula Rodriguez-Miguelez, PhD
Claim this profileStudies Lung Disease
Studies Chronic Obstructive Pulmonary Disease
1 reported clinical trial
2 drugs studied
Area of expertise
1Lung Disease
Stage III
Stage II
Stage IV
2Chronic Obstructive Pulmonary Disease
Stage III
Stage II
Stage IV
More about Paula Rodriguez-Miguelez, PhD
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Paula Rodriguez-Miguelez, PhD has experience with
- MitoQ
- Placebo
Breakdown of trials Paula Rodriguez-Miguelez, PhD has run
Lung Disease
Chronic Obstructive Pulmonary Disease
Obstructive Airway Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paula Rodriguez-Miguelez, PhD specialize in?
Paula Rodriguez-Miguelez, PhD focuses on Lung Disease and Chronic Obstructive Pulmonary Disease. In particular, much of their work with Lung Disease has involved Stage III patients, or patients who are Stage II.
Is Paula Rodriguez-Miguelez, PhD currently recruiting for clinical trials?
No, Paula Rodriguez-Miguelez, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Paula Rodriguez-Miguelez, PhD has studied deeply?
Yes, Paula Rodriguez-Miguelez, PhD has studied treatments such as MitoQ, Placebo.
What is the best way to schedule an appointment with Paula Rodriguez-Miguelez, PhD?
Apply for one of the trials that Paula Rodriguez-Miguelez, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.